₹18.79 Crores | Listing at BSE | Wed, Feb 15, 2023 - Tue, Feb 28, 2023
Shukra Pharmaceuticals Limited Rights Issue comprises 0.9394 Cr equity shares aggregating to ₹18.79 Cr, offered at an issue price of ₹20 per share with a face value of ₹10 per share.
The record date for determining eligible shareholders is Feb 2, 2023.
As per the terms of payment, ₹20 per share payable on application, with the balance payable in call(s).
The Rights Entitlements are expected to be credited to eligible demat accounts on Feb 13, 2023.
The Rights Issue opens on Feb 15, 2023 and closes on Feb 28, 2023.
The deemed date of allotment is Mar 8, 2023, following which the equity shares are expected to be credited to demat accounts on Mar 14, 2023 and listed on the BSE on Mar 15, 2023.
Purva Sharegistry (India) Pvt.Ltd. is the Registrar to the Issue.
Investors are advised to refer to the Shukra Pharmaceuticals Limited Letter of Offer for detailed information, including risk factors, issue terms, and procedural details.
Record Date
Thu, Feb 2, 2023
Entitlement Ratio
:
Open Date
Wed, Feb 15, 2023
Close Date
Tue, Feb 28, 2023
| Period Ended | Total Assets | Total Revenue | Profit After Tax | Net Worth |
|---|---|---|---|---|
| 31-Mar-21 | 35.61 | 11.55 | 0.19 | 15.60 |
| 31-Mar-22 | 35.11 | 20.57 | 0.75 | 16.35 |
| Amount in ₹ Crore | ||||
Shukra Pharmaceuticals Limited is engaged in the field of Pharmaceuticals. They started their operations with a fully integrated plant in Rakanpor in Kalol, Gandhinagar - Gujarat. Even since its incorporation, the company has grown to immense heights in terms of operations and has expanded largely. Today, they have an internationally accredited Laboratory in Ahmedabad for creating each product on the highest quality standards.
Shukra Pharmaceuticals undertake operations including-
The team of research analysts, medical officers, and technical experts of Shukra Pharmaceuticals ensure quality in each product and follow stringent regulations to deliver the same.
The Company proposes to utilize the Net Proceeds to:
[Dilip Davda] Though prima facie this RI appears attractively priced at a hefty discount to its current market price, this is purely due to market operations by vested interest parties. A six-fold rise in its paid-up equity capital post-RI may pose servicing issues. Hence well-informed/cash surplus risk takes may consider investors, others may avoid. Read detail review...
Shukra Pharmaceuticals Limited
Veer House, 3rd Floor, Judges Bungalow Road,
Opp. WIAA Motor Training School,
Bodakdev, Ahmedabad- 380054
Ahmedabad, Gujarat, 380054
Purva Sharegistry (India) Pvt.Ltd.
The Shukra Pharmaceuticals Rights Issue 2023 opens on Wed, Feb 15, 2023, and closes on Tue, Feb 28, 2023.
Shukra Pharmaceuticals Rights Issue 2023 Schedule
| Last Date for credit of Rights Entitlements | Mon, Feb 13, 2023 |
| Last Date for renunciation of Rights Entitlements | Thu, Feb 23, 2023 |
| Issue Opening Date | Wed, Feb 15, 2023 |
| Issue Closing Date | Tue, Feb 28, 2023 |
| Date of Allotment (on or about) | Wed, Mar 8, 2023 |
| Date of Credit (on or about) | Tue, Mar 14, 2023 |
| Date of Listing (on or about) | Wed, Mar 15, 2023 |
You can apply for Shukra Pharmaceuticals Rights Issue 2023 in two ways:
Steps to apply for Shukra Pharmaceuticals Rights Issue 2023 using Net Banking (ASBA)
Steps to apply for Shukra Pharmaceuticals Rights Issue 2023 using Registrar's website (R-WAP)
